Rojas Sebastian V, Trinh-Adams Mai Linh, Uribarri Aitor, Fleissner Felix, Iablonskii Pavel, Rojas-Hernandez Sara, Ricklefs Marcel, Martens Andreas, Rümke Stefan, Warnecke Gregor, Cebotari Serghei, Haverich Axel, Ismail Issam
Department of Cardiothoracic-, Transplantation- and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Department of Cardiology, Complejo Hospitalario de Navarra, Pamplona, Spain.
J Thorac Dis. 2019 Nov;11(11):4444-4452. doi: 10.21037/jtd.2019.11.08.
In non-ST-elevation myocardial infarction (NSTEMI) there is no consensus regarding optimal time point for coronary artery bypass grafting (CABG). Recent findings suggest that long-term outcomes are improved in early-revascularized NSTEMI patients. However, it has been stated that early surgery is associated to increased operative risk. In this study, we wanted to elucidate if early CABG in non-ST-elevation acute coronary syndrome can be performed safely.
We performed a monocentric-prospective observational study within a 2-year interval. A total of 217 consecutive patients (41 female, age 68.9±10.2, ES II 6.62±8.56) developed NSTEMI and underwent CABG. Patients were divided into two groups according to the time point of coronary artery bypass after symptom onset (group A: <72 h; group B: >72 h). Endpoints included 6-month mortality and incidence of MACE (death, stroke or re-infarction).
There were no differences regarding mortality between both groups (30 days: group A 2.4% . group B 3.7%; P=0.592; 6 months: 8.4% . 6.0%; P=0.487). Incidence of MACE in the 6-month follow-up was also similar in both groups (group A: 9.6% . 9.7%, P=0.982). Regression analysis revealed as independent risk factors for mortality in the entire cohort ES II OR 1.045 (95% CI: 1.004-1.088). ES II remained an independent prognostic factor in group A OR 1.043 (95% CI: 1.003-1.086) and group B OR 1.032 (95% CI: 1.001-1.063).
Early revascularized patients showed a higher level of illness. However, results of early CABG were comparable to those following delayed revascularization. Moreover, EuroSCORE II was determined as independent risk factors for mortality.
在非ST段抬高型心肌梗死(NSTEMI)中,关于冠状动脉旁路移植术(CABG)的最佳时间点尚无共识。最近的研究结果表明,早期血运重建的NSTEMI患者的长期预后有所改善。然而,有人指出早期手术与手术风险增加有关。在本研究中,我们想阐明非ST段抬高型急性冠状动脉综合征患者早期进行CABG是否安全。
我们在2年的时间间隔内进行了一项单中心前瞻性观察研究。共有217例连续患者(41例女性,年龄68.9±10.2,欧洲心脏手术风险评估系统(EuroSCORE)II评分为6.62±8.56)发生NSTEMI并接受了CABG。根据症状发作后冠状动脉旁路移植的时间点将患者分为两组(A组:<72小时;B组:>72小时)。终点包括6个月死亡率和主要不良心血管事件(MACE,死亡、中风或再梗死)的发生率。
两组之间的死亡率无差异(30天:A组2.4%,B组3.7%;P=0.592;6个月:8.4%,6.0%;P=0.487)。两组在6个月随访中的MACE发生率也相似(A组:9.6%,9.7%,P=0.982)。回归分析显示,在整个队列中,欧洲心脏手术风险评估系统II评分为死亡率的独立危险因素,比值比(OR)为1.045(95%置信区间:1.004-1.088)。在A组中,欧洲心脏手术风险评估系统II评分仍然是独立的预后因素,OR为1.043(95%置信区间:1.003-1.086),在B组中,OR为1.032(95%置信区间:1.001-1.063)。
早期血运重建的患者病情较重。然而,早期CABG的结果与延迟血运重建后的结果相当。此外,欧洲心脏手术风险评估系统II评分被确定为死亡率的独立危险因素。